Cyclooxygenase Two Inhibitors, Etoricoxib, Periodontitis, Saliva, Superoxide Dismutase
Conditions
Keywords
Cyclooxygenase two inhibitors, Etoricoxib, Periodontitis, Superoxide dismutase, Saliva
Brief summary
The hypothesis is that Etoricoxib act as an adjuvant to SRP in alleviating periodontal inflammation by: 1. improving clinical periodontal parameters and, 2. improving the salivary SOD levels.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
Forty patients with chronic generalized periodontitis \-
Exclusion criteria
with system illnesses, allergies, pregnancy, history of any drug intake and periodontal treatment in past 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| change from baseline in salivary SOD level | 3 months |
Countries
India